annual EBIT:
$252.84M+$346.50M(+369.98%)Summary
- As of today (July 1, 2025), PTGX annual earnings before interest & taxes is $252.84 million, with the most recent change of +$346.50 million (+369.98%) on December 31, 2024.
- During the last 3 years, PTGX annual EBIT has risen by +$378.69 million (+300.92%).
- PTGX annual EBIT is now at all-time high.
Performance
PTGX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$19.31M-$146.09M(-115.23%)Summary
- As of today (July 1, 2025), PTGX quarterly earnings before interest & taxes is -$19.31 million, with the most recent change of -$146.09 million (-115.23%) on March 1, 2025.
- Over the past year, PTGX quarterly EBIT has dropped by -$225.62 million (-109.36%).
- PTGX quarterly EBIT is now -109.36% below its all-time high of $206.31 million, reached on March 31, 2024.
Performance
PTGX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$27.22M-$225.62M(-89.23%)Summary
- As of today (July 1, 2025), PTGX TTM earnings before interest & taxes is $27.22 million, with the most recent change of -$225.62 million (-89.23%) on March 1, 2025.
- Over the past year, PTGX TTM EBIT has dropped by -$121.45 million (-81.69%).
- PTGX TTM EBIT is now -89.23% below its all-time high of $252.84 million, reached on December 31, 2024.
Performance
PTGX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PTGX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +370.0% | -109.4% | -81.7% |
| 3 y3 years | +300.9% | +8.5% | +122.2% |
| 5 y5 years | +425.4% | +1.8% | +138.5% |
PTGX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +292.5% | -109.4% | +54.4% | -89.2% | +117.8% |
| 5 y | 5-year | at high | +292.5% | -109.4% | +54.4% | -89.2% | +117.8% |
| alltime | all time | at high | +292.5% | -109.4% | +54.4% | -89.2% | +117.8% |
PTGX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$19.31M(-115.2%) | $27.22M(-89.2%) |
| Dec 2024 | $252.84M(-370.0%) | $126.78M(-405.8%) | $252.84M(+69.6%) |
| Sep 2024 | - | -$41.45M(+6.9%) | $149.11M(-2.1%) |
| Jun 2024 | - | -$38.79M(-118.8%) | $152.24M(+2.4%) |
| Mar 2024 | - | $206.31M(+795.1%) | $148.68M(-258.8%) |
| Dec 2023 | -$93.65M(-28.7%) | $23.05M(-160.1%) | -$93.65M(-38.9%) |
| Sep 2023 | - | -$38.33M(-9.5%) | -$153.22M(+4.1%) |
| Jun 2023 | - | -$42.35M(+17.6%) | -$147.19M(+0.6%) |
| Mar 2023 | - | -$36.02M(-1.4%) | -$146.28M(+11.3%) |
| Dec 2022 | -$131.37M(+4.4%) | -$36.52M(+13.0%) | -$131.37M(-0.4%) |
| Sep 2022 | - | -$32.30M(-22.1%) | -$131.87M(-1.2%) |
| Jun 2022 | - | -$41.44M(+96.3%) | -$133.50M(+8.6%) |
| Mar 2022 | - | -$21.11M(-43.0%) | -$122.94M(-2.3%) |
| Dec 2021 | -$125.84M(+95.9%) | -$37.02M(+9.1%) | -$125.84M(+17.0%) |
| Sep 2021 | - | -$33.93M(+9.9%) | -$107.59M(+32.2%) |
| Jun 2021 | - | -$30.88M(+28.6%) | -$81.41M(+18.7%) |
| Mar 2021 | - | -$24.02M(+28.1%) | -$68.61M(+6.8%) |
| Dec 2020 | -$64.25M(-17.3%) | -$18.76M(+142.2%) | -$64.25M(+3.7%) |
| Sep 2020 | - | -$7.74M(-57.2%) | -$61.96M(-12.4%) |
| Jun 2020 | - | -$18.08M(-8.0%) | -$70.73M(-15.2%) |
| Mar 2020 | - | -$19.66M(+19.3%) | -$83.45M(+7.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$77.71M(+95.6%) | -$16.48M(-0.2%) | -$77.71M(+4.9%) |
| Sep 2019 | - | -$16.51M(-46.4%) | -$74.10M(+10.6%) |
| Jun 2019 | - | -$30.80M(+121.3%) | -$66.98M(+47.5%) |
| Mar 2019 | - | -$13.92M(+8.2%) | -$45.41M(+14.3%) |
| Dec 2018 | -$39.72M(+7.5%) | -$12.87M(+37.0%) | -$39.72M(+35.0%) |
| Sep 2018 | - | -$9.39M(+1.6%) | -$29.43M(+17.6%) |
| Jun 2018 | - | -$9.24M(+12.3%) | -$25.02M(-19.1%) |
| Mar 2018 | - | -$8.23M(+219.8%) | -$30.91M(-16.4%) |
| Dec 2017 | -$36.96M(+13.1%) | -$2.57M(-48.3%) | -$36.96M(-19.3%) |
| Sep 2017 | - | -$4.98M(-67.1%) | -$45.78M(-4.5%) |
| Jun 2017 | - | -$15.13M(+6.0%) | -$47.94M(+20.2%) |
| Mar 2017 | - | -$14.27M(+25.2%) | -$39.90M(+22.1%) |
| Dec 2016 | -$32.67M(+120.8%) | -$11.40M(+59.7%) | -$32.67M(+24.3%) |
| Sep 2016 | - | -$7.14M(+0.7%) | -$26.27M(+13.5%) |
| Jun 2016 | - | -$7.09M(+0.7%) | -$23.15M(+20.9%) |
| Mar 2016 | - | -$7.04M(+40.8%) | -$19.14M(+29.4%) |
| Dec 2015 | -$14.79M(+58.8%) | -$5.00M(+24.4%) | -$14.79M(+51.1%) |
| Sep 2015 | - | -$4.02M(+30.4%) | -$9.79M(+69.7%) |
| Jun 2015 | - | -$3.08M(+14.7%) | -$5.77M(+114.7%) |
| Mar 2015 | - | -$2.69M | -$2.69M |
| Dec 2014 | -$9.32M | - | - |
FAQ
- What is Protagonist Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual EBIT year-on-year change?
- What is Protagonist Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly EBIT year-on-year change?
- What is Protagonist Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM EBIT year-on-year change?
What is Protagonist Therapeutics annual earnings before interest & taxes?
The current annual EBIT of PTGX is $252.84M
What is the all time high annual EBIT for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual earnings before interest & taxes is $252.84M
What is Protagonist Therapeutics annual EBIT year-on-year change?
Over the past year, PTGX annual earnings before interest & taxes has changed by +$346.50M (+369.98%)
What is Protagonist Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of PTGX is -$19.31M
What is the all time high quarterly EBIT for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly earnings before interest & taxes is $206.31M
What is Protagonist Therapeutics quarterly EBIT year-on-year change?
Over the past year, PTGX quarterly earnings before interest & taxes has changed by -$225.62M (-109.36%)
What is Protagonist Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of PTGX is $27.22M
What is the all time high TTM EBIT for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM earnings before interest & taxes is $252.84M
What is Protagonist Therapeutics TTM EBIT year-on-year change?
Over the past year, PTGX TTM earnings before interest & taxes has changed by -$121.45M (-81.69%)